Literature DB >> 18553272

Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa.

Ai-Lin Liu1, Bo Liu, Hai-Lin Qin, Simon Mingyuen Lee, Yi-Tao Wang, Guan-Hua Du.   

Abstract

ELSHOLTZIA RUGULOSA (Lamiaceae), a common Chinese herb, is widely used in the treatment of cold and fever. In order to elucidate the action mechanism and the active principles from the plant against anti-influenza virus, the influenza virus neuraminidase (NA) activity assay and IN VITRO antiviral activity assay were established, and the isolation of the active principles was guided by NA activity. Finally, 5 active constituents were obtained, namely apigenin ( 1), luteolin ( 2), apiin ( 3), galuteolin ( 4) and luteolin 3'-glucuronyl acid methyl ester ( 5), respectively. They all belong to the flavonoids. The IN VITRO antiviral assay using a cytopathic effect (CPE) reduction method showed that they all possessed anti-influenza virus activity. Among them, apigenin and luteolin exhibited the highest activities against influenza virus (H3N2) with IC (50) values of 1.43 microg/mL and 2.06 microg/mL, respectively. The structure-activity relationship (SAR) of these flavonoids with different chemical structures and their anti-influenza virus activities was addressed in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18553272     DOI: 10.1055/s-2008-1074558

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  34 in total

1.  Predicting the preferred conformations of luteolin-4'-O-β-D-glucoside in gas phase: a comparison of two computational approaches.

Authors:  Yongzhi Li; Xiuhua Liu; Dong Chen; Zhichao Wei; Bo Liu
Journal:  J Mol Model       Date:  2013-06-09       Impact factor: 1.810

2.  Inhibitory effects and related molecular mechanisms of total flavonoids in Mosla chinensis Maxim against H1N1 influenza virus.

Authors:  Xiao-Xia Zhang; Qiao-Feng Wu; Yun-Liang Yan; Feng-Ling Zhang
Journal:  Inflamm Res       Date:  2017-11-24       Impact factor: 4.575

Review 3.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

4.  Effect of sesamin against cytokine production from influenza type A H1N1-induced peripheral blood mononuclear cells: computational and experimental studies.

Authors:  Kanda Fanhchaksai; Kanchanok Kodchakorn; Peraphan Pothacharoen; Prachya Kongtawelert
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-09-30       Impact factor: 2.416

5.  Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression.

Authors:  Haiyan Yan; Linlin Ma; Huiqiang Wang; Shuo Wu; Hua Huang; Zhengyi Gu; Jiandong Jiang; Yuhuan Li
Journal:  J Nat Med       Date:  2019-02-13       Impact factor: 2.343

6.  Multiple pathways in prevention of immune-mediated brain disorders: Implications for the prevention of autism.

Authors:  S Hossein Fatemi
Journal:  J Neuroimmunol       Date:  2009-10-14       Impact factor: 3.478

7.  Antiviral activity of 3,4'-dihydroxyflavone on influenza a virus.

Authors:  Mohammed Kawser Hossain; Hye Yeon Choi; Jae-Seon Hwang; Ahmed Abdal Dayem; Jung-Hyun Kim; Young Bong Kim; Haryoung Poo; Ssang-Goo Cho
Journal:  J Microbiol       Date:  2014-05-29       Impact factor: 3.422

Review 8.  Matching the power of high throughput screening to the chemical diversity of natural products.

Authors:  Curtis J Henrich; John A Beutler
Journal:  Nat Prod Rep       Date:  2013-08-08       Impact factor: 13.423

Review 9.  Substantial effect of phytochemical constituents against the pandemic disease influenza-a review.

Authors:  A Brindha Devi; R Sarala
Journal:  Futur J Pharm Sci       Date:  2021-06-12

Review 10.  Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.

Authors:  Mohammad Amin Khazeei Tabari; Amin Iranpanah; Roodabeh Bahramsoltani; Roja Rahimi
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.